Resumption of virus production after human immunodeficiency virus infection of T lymphocytes in the presence of azidothymidine.

The new antiviral agent, azidothymidine (AZT; BW A509U), is currently the only successful drug in use for patients with acquired immunodeficiency syndrome. The effect of this thymidine analog, 3'-azido-3'-deoxythymidine, on the replication of the lymphadenopathy-associated virus strain of the human...

Deskribapen osoa

Xehetasun bibliografikoak

Argitaratua izan da:	J Virol
Egile Nagusiak:	Smith, M S, Brian, E L, Pagano, J S
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	American Society for Microbiology (ASM) 1987
Gaiak:	Research Article
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC255991/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2446006/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.61.12.3769-3773.1987
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!